Closed-loop insulin system study for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an automated insulin delivery system that combines a pump and a continuous glucose monitor to help keep blood sugar levels stable. People with type 1 diabetes may have better glucose control and quality of life while using this system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 1 diabetes.
- If you are 2 years or older (or 4 years or older if using a different sensor), you may be eligible.
- Your diabetes doctor has agreed that you will use this closed-loop system as part of your treatment.
- You need a compatible smartphone and an email address and mobile phone number.
- You have not used any hybrid closed-loop, fully closed-loop, or DIY closed-loop system in the past 6 months.
- You must be able to read and understand French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system (mylife CamAPS FX) for people with type 1 diabetes. It aims to see how well the system works when paired with a Dexcom G6 continuous glucose monitor.
This trial tests a 'closed-loop' system that automatically adjusts insulin delivery for people with type 2 diabetes. If you already use insulin and certain diabetes medications, this study could help see if a smart insulin pump improves blood sugar control.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
Hear when a new Diabetes Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.